A 40-year-old hypothyroid female who had been treated with synthetic thyroxine was admitted to our hospital in October 1988 due to abnormal liver function tests. She had low serum free triiodothyronine (T3; 2.3pg/ml) and high serum thyrotropin (TSH; 20.8 /iU/ml) concentrations. On the other hand, the serum free thyroxine (FT4) level was inappropriately high, being 2.46 ng/dl. Immuneprecipitation of radiolabeled thyroid hormones with her serum disclosed the binding of 125I-T3 and 125I-T4 to the extent of 9.5% and ll.3%, respectively (normal ranges for 125I-T3 and 125I-T4 binding are less than 6.3% and 5.9%, respectively). 125I-T4 binding to the patient's serum gammaglobulin was completely displaced with the addition of unlabeled T4. Further examination disclosed that anti-T4 antibodies in her serum belong to IgG k class immunoglobulin. (Internal Medicine 32: 21-25, 1993) 
Introduction
It has been knownthat the presence of circulating antithyroid hormone antibodies can cause an apparent but artifactual effect on the result of radioimmunoassay (RIA) for serum total and free serum thyroxine (T4) and triiodothyronine (T3) (1) (2) (3) . Earlier studies have documented that such autoantibodies are present not only in various thyroidal diseases but also in nonthyroidal disorders such as Waldenstrom macroglobulinemia (4), hepatocellular carcinoma (5) and systemic lupus erythematosus (SLE) (6). Recently, we have experienced a case of autoimmune hepatitis and hypothyroidism who had an unusually high level of serum free thyroxine (FT4). Examination of her serum disclosed the presence of anti-T4 antibodies which belong to IgG kclass immunoglobulin. Since no reports have discussed the presence of anti-thyroid hormoneantibodies in the serum of a patient with autoimmunehepatitis, this report provides additional information concerning the production of anti-thyroid hormone autoantibodies in such a disease entity.
Materials and Methods
Serum concentrations of free T3 (FT3) and free T4 (FT4) were measured by commercially available RIA kits (Amerlex FT3 and FT4 RIA kit, Amersham, Tokyo incubation an equal amount of 25%polyethylene glycol (PEG 6000, Wako Chemicals, Osaka) was added and the radioactivity of the precipitate after centrifugation (2,000 x g, 30min) was counted. The titer of anti-thyroid hormone antibodies was expressed as bound %of radioactivity of added 125I-T3 or 125I-T4. Percent of 125I-T3 and 125I-T4 bound to five healthy subjects were 5.4 ± 0.3 and 5.0 ± 0.3 (mean ± SD), respectively. Based on this result a bound % value of mean4-3SD or higher (125I-T3; 6.3% , 125I-T4; 5.9% ) was considered as antibody positive.
Since preliminary data using 25/i serum from the patient showed higher % bound with serum gamma globulin (41.0% , normal range 5.9 ± 1.1%) by analogue 125I-T4 (polyaminocarboxy T4, Amerlex FT4 RIA kit, Amersham International, Tokyo) than 125I-T4 (ll.3%), characterization of chain specificity was done by 125I-T4 analogue. Briefly, 10/il of serum was incubated with 125I-T4 (12,000cpm) analogue (polyaminocarboxy T4, 12,000 cpm) for 20 hour at 25°C, followed by precipitation with 200 (A of chain specific rabbit anti-human immuno-
anti-a, anti-<5, anti-s); MBL Lab, Nagoya, Japan, and light chain antibodies (anti-ic, anti-A); Miles Lab. , USA). Chain specificity of anti-thyroglobulin (Tg) antibodies in the patient was also tested. Briefly, 50pUi of serum which had been diluted to 1/50 with distilled water was incubated with 125I-human Tg (Eiken, Tokyo) for 20 hour at 25°C, followed by precipitation with 200[A of chain specific rabbit anti-human immunoglobulins. Same experiment of immune precipitation was done using sera obtained from two healthy volunteers (Nl and N2).
Case Report
A 40-year-old female, who had abnormal liver function tests and hypothyroidism and had been treated with 25 -lOO jUg/day of synthetic L-thyroxine since February 1977, was admitted to our hospital on October ll, 1988, because of abnormal liver function tests.
On physical examination, she was 154cm tall and her body weight was 70kg. Her blood pressure was 150/90 mmHg and pulse rate was 88/min and was regular. Her skin was slightly dry. She had a slightly enlarged thyroid gland which was rubbery hard. There was no tenderness around the thyroid gland. Neither enlarged parotid gland nor dry mouth and dry eye was observed. Schirmer's test was negative for dry eye (r= 12mm, / = 14mm). She never experienced Raynaud's phenomenon nor purpura. Auscultation of the lungs and chest roentgenogramwere unremarkable. Both Achilles and patellar jerks were normal. There was no pretibial edema. Routine laboratory data and results of thyroid function tests on admission are shown in Table 1 (HAV), B (HBV) and C (HCV) infection were negative.
Since she had positive lymphocyte blastogenesis test against T4, drug-induced hepatitis was suspected and 10/ig daily of L-T3 was administered instead of L-T4.
However, the progressive deterioration of liver function (Fig. 1) Treatment ' 25 ' |~^T p^-^p»:"^^,-t. tests was again observed when PSL therapy was shifted to alternative day of 10mg and 5mg administration.
However, it normalized again when PSL was increased to 15mg daily.
Discussion
The present case presented with abnormal liver function tests with negative serum hepatitis A, B and C virus markers, which improved by prednisolone treatment and deteriorated upon withdrawal of prednisolone. There were also high titers of anti-nuclear and anti-DNA antibodies and high concentration of serum gamma globulin (3.0g/dl). Although, liver biopsy was unsuccessful and we were unable to confirm histopathology of liver, a diagnosis of autoimmunehepatitis was madefrom laboratory data (8). Concerning the liver dysfunction, drug-induced liver damage by T4 was considered first.
Since lymphocyte blastogenesis test against T4 was positive, T3 was administered instead of T4. However, liver function tests did not improve. In addition, none of the authors so far reported drug induced liver dysfunction by T4 administration, the possibility of T4-induced liver damage is highly unlikely. have Hashimoto's thyroiditis (1) . The exact underlying mechanism for the production of these autoantibodies in these patients however, is not clear, since none of the reports so far have described that anti-thyroid hormone antibodies may be present in the absence of Hashimoto's thyroiditis in autoimmune hepatitis patients, we think that in the present case, the coexisting Hashimoto's thyroiditis could be responsible for the production of anti-thyroid hormone autoantibodies. Anti-T4 antibodies in this patient belonged to IgG k. It has been reported that among 10 patients with thyroid hormone autoantibodies, 4 had A chain, 2 had kchain, and 4 had both A and k chain specificities (1) . Anti-Tg antibodies in her serum showed both A and k chain specificities. The clinical significance of the chain specificity of anti-T4
antibodies is, thus not clear. It indicates, however, some restriction of antibody production against T4. Autoimmunehepatitis is a disease entity of hepatitis induced by an autoimmune mechanism (13, 14). A high incidence of the association of other autoimmune diseases such as rheumatoid arthritis (ll.6%), Sjogren's syndrome (10.4%), and Hashimoto's thyroiditis (8.8%) (9) has been reported. Therefore, local and/or systemic immunologic abnormalities in autoimmune hepatitis could have caused the production of anti-thyroid hormone autoantibodies.
Clinically, anti-thyroid hormone autoantibodies in patients' sera interfere with radioimmunoassay results of thyroid hormones (1) (2) (3) . This interference confuses clinicians on the evaluation of the actual patients' thyroid state. In fact, in the present study, the patient had high serum TSHconcentrations with a high serum FT4 level and a low normal serum FT3 level. Since it has been reported that serum thyrotropin (TSH) concentration is a good indicator of thyroid state in such patients (1) 
